Moderna CEO just announced a new mRNA ππ to treat heart failure π
https://investors.modernatx.com/news/news-details/2023/Moderna-Announces-Advances-Across-mRNA-Pipeline-and-Provides-Business-Update/default.aspx
#Moderna #HeartFailure #CardiacVaccine
https://investors.modernatx.com/news/news-details/2023/Moderna-Announces-Advances-Across-mRNA-Pipeline-and-Provides-Business-Update/default.aspx
#Moderna #HeartFailure #CardiacVaccine
Modernatx
Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
COVID-19 vaccine sales for 2022 approximately $18.4 billion (unaudited) Reiterating 2023 expected minimum COVID-19 vaccine sales of approximately $5.0 billion; continue to expect additional contracts for 2023 Company continues to scale with 48 programs inβ¦
Modernas newest Bio-Weapon set to go Straight to the heart ππ«π
https://ijr.com/moderna-begins-administering-new-mrna-shot-injected-directly-heart/
#Moderna #CardiacVaccine #modernacardiacvaccine
https://ijr.com/moderna-begins-administering-new-mrna-shot-injected-directly-heart/
#Moderna #CardiacVaccine #modernacardiacvaccine
IJR
Moderna Begins Administering New MRNA Shot That Is Injected Directly Into the Heart
Moderna is currently developing an mRNA shot that aims to help the body produce relaxin, a hormone that can increase